Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

SHE:300122 Revenue

Chongqing Zhifei Biological Products had revenue of 1.87B CNY in the quarter ending June 30, 2026, a decrease of -27.24%. This brings the company's total for the last twelve months to 8.05B, down -36.68% year-over-year. In the year 2025, Chongqing Zhifei Biological Products had annual revenue of 8.96B, down -65.61%. That makes Chongqing Zhifei Biological Products the 6,807th largest company in the world by revenue and 959th in China.

• Revenue (ttm): 8.05B
• Revenue Growth: -36.68%
• P/S Ratio: 3.69
• Revenue / Employee: 1.28M
• Employees: 6,292
• Market Cap: 29.85B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biochemical Product 8.87B 99.0%
• Unallocated Others 90.42M 1.0%

By Geography

Chart

• Eastern China 2.61B 29.2%
• South China 1.91B 21.3%
• Southwest China 1.29B 14.4%
• Central China 1.21B 13.5%
• North China 1.04B 11.6%
• Northwest China 540.14M 6.0%
• Northeast China 326.77M 3.6%
• Export 34.70M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHE:300122 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.96B	-17.09B	-65.61%
Dec 31, 2024	26.05B	-26.87B	-50.77%
Dec 31, 2023	52.92B	14.65B	38.30%
Jan 1, 2023	38.26B	7.61B	24.83%
Dec 31, 2021	30.65B	15.46B	101.79%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error